Skip to main content
Figure 3 | Journal of Experimental & Clinical Cancer Research

Figure 3

From: Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial

Figure 3

Survival analysis in patients under adjuvant 5-FU/FA/irinotecan in relation to AREG/EREG- expression. A. Disease-free survival in relation to AREG expression on tumor tissues. B. Disease-free survival in relation to EREG expression on tumor tissues. C. Disease-free survival in relation to AREG and EREG expression on tumor tissues.

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us